ARTICLE | Company News
Fudan University, Huya deal
March 28, 2016 7:00 AM UTC
The university granted Huya exclusive, ex-Chinese rights to undisclosed immuno-oncology compounds that inhibit indoleamine 2,3-dioxygenase (INDO; IDO). The partners did not respond to inquiries. ...